CSF1R and neoplasm: Sun et al. demonstrated how macrophage phenotype could be exploited to exert anti-tumor effects by treating macrophages with an inhibitor of the CSF1R, thus making them switch from M2 to M1 phenotype and stimulating phagocytosis of tumor cells.